Archive

Everything Everywhere All at Null

Five trials, four "negative" headlines, and why the nulls are the most useful thing you'll read before Monday rounds.

September 2026: The Munich Sessions: Statins Grow Old Gracefully, Endocarditis Gets the Short Course, and COPD Finally Gets Its Biologic

Five practice-shapers from a summer dominated by ESC and ERS, plus the pearls worth your Monday.

August 2026: The Summer Blockbuster Issue: Aspirin Wins, Kidneys Win, and an Old Antibiotic Makes a Comeback

July 2026: Cefazolin Wins. Colonoscopy Draws. Asundexian Changes the Game.

June 2026: Aspirin, Impella, and a Sepsis Tool That Shouldn't Work But Does